Poolbeg Pharma PLC Announces AI Led Programme Identifies Influenza ...
Poolbeg Pharma PLC Announces AI Led Programme Identifies Influenza ...
Stay updated with breaking news from Artificial Intelligence Ai Programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Poolbeg Pharma PLC Announces AI Led Programme Identifies Influenza ...
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington and CytoReason co-founder and CEO David Harel speak to Thomas Warner from Proactive after...
Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company focusing on infectious and other prevalent diseases with a high unmet medical need, announces a significant breakthrough in its world first influenza Artificial Intelligence ('AI') Programme with ...
Poolbeg Pharma Novel influenza drug targets identified faster with AI programme
Results for the year ended 31 December 2022 Significant milestones reached, well capitalised and positioned for future growth LONDON, UK / ACCESSWIRE / March